Neurotechnology Startups

BIOS develops neural digital therapy technology to deliver treatments for neurological conditions. The company combines neural engineering with AI and machine learning to improve healthcare outcomes and restore patient control over bodily function.

5 investors

Piramidal bridges in-vivo and in-silico intelligence for neuroscience research and clinical applications. The company develops technology that integrates biological data with computational intelligence.

5 investors

Mindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.

4 investors

BrainKey develops artificial intelligence and medical imaging analysis tools for neuroimaging data interpretation. The company serves physicians and patients by making brain anatomy measurable, visible, and more interpretable through advanced analytical software.

3 investors

Craniometrix provides AI-powered care navigation and support services to help dementia patients remain at home while reducing hospitalizations for their families and caregivers.

3 investors

Rain Neuromorphics manufactures AI processors using neuromorphic hardware—physical neural networks with spiking neurons and memristive nanowires—that consume significantly less power than conventional processors for machine learning applications.

3 investors

An AI research organization that develops interface innovations and neural technologies, focusing on human-AI interaction breakthroughs including neural signal processing and thought decoding methods.

2 investors

Nectome provides cryogenic preservation of the human body and brain shortly after legal death, aiming to preserve neural structure in sufficient detail that future revival may become theoretically possible. The service targets individuals at end-of-life seeking experimental preservation as a potential pathway to future recovery.

2 investors

Actipulse Neuroscience develops non-invasive brain stimulation technologies using high-frequency magnetic pulses to treat central nervous system disorders, including major depressive disorder and neurodegenerative diseases. The company conducts clinical research on transcranial neuromodulation devices.

1 investor

Auricle develops a neurostimulation implant designed to restore hearing for patients who do not benefit from hearing aids or existing solutions.

1 investor

Circumvent develops precision medicines for neurodegenerative diseases, with current focus on Batten Disease and other rare neurological disorders. The company's research targets synaptic dysfunction and lysosomal pathways through investigation of the palmitoylome.

1 investor

Exin Therapeutics develops an AI-guided drug discovery platform that uses experimental mouse studies to identify neurological therapies, starting with epilepsies linked to autism and Parkinson's disease. The company trains machine learning models on proprietary multimodal neuroscience data to guide its therapeutic screening process.

1 investor

Parasma develops algorithms and infrastructure to train living neural systems for computation, aiming to make advanced AI far more energy-efficient and accessible by leveraging biological neurons as programmable compute. The company serves organizations seeking to reduce the energy footprint and hardware costs of AI systems.

1 investor

Prophecy Sciences develops cognitive assessments that combine behavioral testing with biosensor measurements to identify and predict workplace performance factors across mental aptitude, personality, and decision-making. The company provides hiring and team management tools for employers seeking to match candidates to roles and optimize team dynamics.

1 investor

1 investor

Torpedo Therapeutics develops high-precision, closed-loop deep brain stimulation devices for treating neurological disorders including Parkinson's disease, essential tremor, dystonia, and drug-resistant epilepsy. The company uses micro- and nano-fabrication to create ultra-small electrode leads with machine learning-driven parameter adjustment to reduce side effects and improve treatment efficacy.

1 investor

Voyage Biomedical develops cooling technology designed to reduce brain injury in stroke patients.

1 investor

Well Principled builds AI models for optimization across multiple domains: consumer durable purchasing behavior for marketing and supply chain planning, battery electrochemistry for materials science, and personalized metabolic modeling for fitness applications.

1 investor